| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |